Crescita Therapeutics (TSX:CTX) Operating Cash Flow per Share : C$0.02 (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Operating Cash Flow per Share?

Crescita Therapeutics's operating cash flow per share for the three months ended in Mar. 2024 was C$0.02. Crescita Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.02.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Crescita Therapeutics was -44.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -27.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Crescita Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

TSX:CTX' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -27.4 Med: 7.4 Max: 60.5
Current: -27.4

During the past 10 years, Crescita Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 60.50% per year. The lowest was -27.40% per year. And the median was 7.40% per year.

TSX:CTX's 3-Year OCF Growth Rate is ranked worse than
85.96% of 805 companies
in the Drug Manufacturers industry
Industry Median: 6.9 vs TSX:CTX: -27.40

Crescita Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Crescita Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Operating Cash Flow per Share Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.24

0.27

-0.08

-0.05

0.10

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.11	-	0.01	-0.01	0.02

Competitive Comparison of Crescita Therapeutics's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Crescita Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescita Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Crescita Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Crescita Therapeutics's Price-to-Operating-Cash-Flow falls into.

Crescita Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Crescita Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	2.076	/	20.255
	=	0.10

Crescita Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	0.378	/	19.592
	=	0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02

Crescita Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines